课题基金 / 基金详情

Epithelial Cell-Derived IL-1-alpha as a Novel Danger Signal in IBD Pathogenesis

Epithelial Cell-Derived IL-1-alpha as a Novel Danger Signal in IBD Pathogenesis
上皮细胞衍生的 IL-1-α 作为 IBD 发病机制中的新型危险信号
批准号:
8668052
负责人:
CLAUDIO FIOCCHI
金额:
$34.15万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-10 至 2016-05-31

项目摘要

项目成果

CLAUDIO FIOCCHI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A fundamental paradigm of IBD pathogenesis is that inflammation results from an inappropriate response to the pathogen-associated molecular patterns (PAMPs) expressed by the gut microbiota. Recent evidence from other immune-mediated disorders indicates that chronic inflammation occurs when PAMP signals are combined with signals derived from tissue damage, the so-called damage-associated molecular patterns (DAMPs). These are released by injured/dead cells and induce a "sterile inflammatory response". DAMPs are numerous, including the high mobility group protein 1 (HMGB1), nucleic acids, uric acid, degradation products of the extracellular matrix, calcium-binding S100 proteins, and many others. DAMPs utilize receptors shared with PAMPs, such as Toll-like receptors (TLRs), but also distinct receptors, co-receptors and accessory molecules to mediate their actions. Some DAMPs have already been identified in IBD, such as HMGB1 and calcium-binding S100 proteins and, therefore, understanding how their signals converge with those coming from PAMPs becomes obviously relevant and will be explored in this proposal. The cytokine IL-1? has been recently identified as a major DAMP released by necrotic cells and is a strong inducer of sterile inflammation. Because the IL-1 cytokine family is involved in IBD, we performed preliminary studies and found that necrotic intestinal epithelial cells release IL-1?, which induces proinflammatory events in the gut. We also found that IL-1? is present in vivo in the epithelium and can trigger experimental colitis. Thus, we propose the novel central hypothesis that epithelial cell-derived IL-1? is a major intestinal DAMP and represents a novel component of IBD pathogenesis. This hypothesis will be tested by 3 specific aims: Aim 1. Characterize the response of human immune and non-immune cells to necrotic cell-derived IL-1? alone and in combination with other DAMPs and PAMPs. Aim 2. Determine the mechanisms by which necrotic cell-derived IL-1? regulates the inflammatory response. Aim 3. Explore the role of necrotic cell-derived IL-1? in induction and modulation of intestinal inflammation in vivo. The innovative concept that epithelial-derived IL-1? can mediate inflammation alone or in association with PAMPs would create a paradigm shift in our current understanding of IBD pathogenesis. Additionally, interfering with the DAMP function of IL-1? may generate new insights into how to modulate intestinal immunity and inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biorepository Core B
  • 批准号:
    10555241
  • 项目类别:
  • 资助金额:
    $22.01万
  • 财政年份:
    2015
  • 负责人:
    CLAUDIO FIOCCHI
  • 依托单位:
Biorepository Core B
  • 批准号:
    10361544
  • 项目类别:
  • 资助金额:
    $22.01万
  • 财政年份:
    2015
  • 负责人:
    CLAUDIO FIOCCHI
  • 依托单位:
Epithelial Cell-Derived IL-1-alpha as a Novel Danger Signal in IBD Pathogenesis
  • 批准号:
    8370976
  • 项目类别:
  • 资助金额:
    $34.15万
  • 财政年份:
    2012
  • 负责人:
    CLAUDIO FIOCCHI
  • 依托单位:
Epithelial Cell-Derived IL-1-alpha as a Novel Danger Signal in IBD Pathogenesis
  • 批准号:
    8542831
  • 项目类别:
  • 资助金额:
    $32.95万
  • 财政年份:
    2012
  • 负责人:
    CLAUDIO FIOCCHI
  • 依托单位:
海外基金